New compounds and compositions as pharmaceuticals for the treatment of diseases and their applications are disclosed herein. Methods for inhibiting KDM1A, increasing gamma globin gene expression, and methods for inducing differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myeloid leukemia.